Fig. 3From: The efficacy and safety of intravitreal injection of Ranibizumab as pre-treatment for vitrectomy in proliferative diabetic retinopathy with vitreous hemorrhageCorrelation between the aqueous humor VEGF and CTGF concentrations in patients who received IVR 1 day (A) and 3 days (B) before vitrectomyBack to article page